SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009616
Filing Date
2023-05-12
Accepted
2023-05-12 16:47:35
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20230331x10q.htm   iXBRL 10-Q 1066856
2 EX-31.1 nviv-20230331xex31d1.htm EX-31.1 13862
3 EX-31.2 nviv-20230331xex31d2.htm EX-31.2 13570
4 EX-32.1 nviv-20230331xex32d1.htm EX-32.1 7525
5 EX-32.2 nviv-20230331xex32d2.htm EX-32.2 7577
  Complete submission text file 0001558370-23-009616.txt   5007136

Data Files

Seq Description Document Type Size
6 EX-101.SCH nviv-20230331.xsd EX-101.SCH 41007
7 EX-101.CAL nviv-20230331_cal.xml EX-101.CAL 39317
8 EX-101.DEF nviv-20230331_def.xml EX-101.DEF 135726
9 EX-101.LAB nviv-20230331_lab.xml EX-101.LAB 331240
10 EX-101.PRE nviv-20230331_pre.xml EX-101.PRE 250139
63 EXTRACTED XBRL INSTANCE DOCUMENT nviv-20230331x10q_htm.xml XML 848087
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 23916647
SIC: 3841 Surgical & Medical Instruments & Apparatus